In the second quarter, Hims & Hers Health reported revenue of around $316 million, up 52% from the year-ago period. It also brought in net income of $13.3 million, and adjusted earnings of $39.3 ...
Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...